Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

被引：0
|
作者：
Hao Cui
Yue Sun
Dantong Zhao
Xudong Zhang
Hanqing Kong
Nana Hu
Panting Wang
Xiaoxuan Zuo
Wei Fan
Yuan Yao
Baiyang Fu
Jiawei Tian
Meixin Wu
Yue Gao
Shangwei Ning
Lei Zhang
机构：
[1] The Second Affiliated Hospital of Harbin Medical University,Department of Ultrasound Medicine
[2] Harbin Medical University,College of Bioinformatics Science and Technology
[3] The Second Affiliated Hospital of Harbin Medical University,Department of Surgery
[4] The Second Affiliated Hospital of Harbin Medical University,Department of Clinical Medicine
来源：
Journal of Translational Medicine | / 21卷
关键词：
Breast cancer; HER2; Radiogenomics; Radiomics; Ultrasound;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer
    Castagnoli, Lorenzo
    Iorio, Egidio
    Dugo, Matteo
    Koschorke, Ada
    Faraci, Simona
    Canese, Rossella
    Casalini, Patrizia
    Nanni, Patrizia
    Vernieri, Claudio
    Di Nicola, Massimo
    Morelli, Daniele
    Tagliabue, Elda
    Pupa, Serenella M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1768 - 1779
  • [42] DCE-MRI Based Analysis of Intratumor Heterogeneity by Decomposing Method for Prediction of HER2 Status in Breast Cancer
    Zhang, Peng
    Fan, Ming
    Li, Yuanzhe
    Xu, Maosheng
    Li, Lihua
    MEDICAL IMAGING 2019: COMPUTER-AIDED DIAGNOSIS, 2019, 10950
  • [43] Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results
    Yan, Meiying
    Yao, Jincao
    Zhang, Xiao
    Xu, Dong
    Yang, Chen
    CANCER MEDICINE, 2024, 13 (03):
  • [44] The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay
    António Polónia
    Carolina Canelas
    Ana Caramelo
    Virchows Archiv, 2022, 480 : 1171 - 1179
  • [45] Assessment of HER2 amplification status in breast cancer using a new automated HER2 IQFISH pharmDx™ (Dako Omnis) assay
    Viale, Giuseppe
    Paterson, Jennifer
    Bloch, Miriam
    Csathy, George
    Allen, David
    Dell'Orto, Patrizia
    Kjaersgaard, Gitte
    Levy, Yaron Y.
    Jorgensen, Jan Trost
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (08) : 735 - 742
  • [46] Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue
    Park, In Hae
    Kwon, Youngmee
    Ro, Jae Y.
    Lee, Keun Seok
    Ro, Jungsil
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) : 125 - 128
  • [47] Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD
    Marques, Raquel C. B.
    Viswanathan, Subramanian
    Nouws, Henri P. A.
    Delerue-Matos, Cristina
    Begona Gonzalez-Garcia, M.
    TALANTA, 2014, 129 : 594 - 599
  • [48] The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay
    Polonia, Antonio
    Canelas, Carolina
    Caramelo, Ana
    VIRCHOWS ARCHIV, 2022, 480 (06) : 1171 - 1179
  • [49] Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer
    Song, Lirong
    Li, Chunli
    Yin, Jiandong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Determination of HER2 Amplification Status in Breast Cancer Cells Using Raman Spectroscopy
    Bi, Xiaohong
    Rexer, Brent
    Arteaga, Carlos L.
    Guo, Mingsheng
    Li, Ming
    Mahadevan-Jansen, Anita
    BIOMEDICAL VIBRATIONAL SPECTROSCOPY IV: ADVANCES IN RESEARCH AND INDUSTRY, 2010, 7560
12345